OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex proteins. Enhancing these processes involves modifying various parameters, including cell line selection, media composition, and bioreactor environments. A key goal is to amplify antibody yield while reducing production costs and